South Korea's KOSDAQ Marks 300th Tech-Exemption Listing in 21 Years, Raising 8 Trillion Won

The Quick Take

• Skylab's listing made KOSDAQ's tech-exemption pathway reach 300 cumulative companies, 21 years after the program launched in 2005
• Total cumulative offering proceeds from the 300 tech-exemption listed companies amount to 8 trillion Korean won
• The program has evolved from a primarily biotech pathway to cover AI, semiconductors, robotics, and space-defense sectors
• Tech-exemption listing allows companies without near-term profitability to list if they demonstrate technological capability and growth potential

The KOSDAQ tech-exemption listing program reached its 300th company milestone with Skylab's listing on September 4, 2026, marking 21 years since the pathway's 2005 introduction. The Korea Exchange confirmed that cumulative offering proceeds from all 300 companies total 8 trillion Korean won, representing a significant capital formation mechanism for South Korea's innovation economy. The program's design explicitly accommodates pre-profitability companies with demonstrable technological capabilities — a structure that has increasingly drawn comparison to NASDAQ's growth-stage listing pathways as South Korea positions itself as a global technology hub.

The composition of tech-exemption listings has shifted meaningfully since the program's biotech-dominated early years, now encompassing AI platforms, advanced semiconductor design houses, robotics manufacturers, and space-defense technology companies. This sector diversification reflects South Korea's strategic industrial policy priorities and the global demand surge for dual-use defense-technology assets. The milestone arrives at a time when KOSDAQ's overall market sentiment is improving, driven by government policy support for technology commercialization and growing cross-border M&A interest in Korean deep-tech assets from Japanese and US strategic investors.

Investors should watch the quality of upcoming tech-exemption listings as an indicator of whether the program maintains rigorous screening or experiences adverse selection as it scales. The post-listing performance of the 300-company cohort's more recent additions will be a key test of whether the shift toward AI and defense names reflects genuine commercial maturity or speculative listing cycles. The macro variable is South Korea's defense export pipeline and global AI semiconductor demand, both of which directly affect the revenue prospects and valuation metrics of the programs' largest new entrants.

Synthesized from 2 sources.